The Formulary is our regular review of pharmacotherapy, or treatment with pharmaceutical drugs. Bookmark this page to keep up to date with the latest developments in drugs and drug treatment, and browse previous instalments of Formulary from the British Journal of Family Medicine archive.
SMC accepts ovarian cancer and lung cancer drugs
Depression and antidepressants associated with increased risk of venous thromboembolism
Cancer drug for children recommended after becoming cost effective for NHS patients
New treatment option for systemic-onset juvenile idiopathic arthritis and adult onset Still’s disease launched in the UK
New supplement could help with management of IBS and other gastrointestinal conditions
Scottish Medicines Consortium accepts three new medicines
Tresiba demonstrates improved blood sugar control compared to insulin glargine in real-world study data
NICE publishes draft guidance recommending MS drug
SMC accepts six new medicines for use by NHSScotland
A treatment with an extended half-life could reduce bleeding episodes in people with haemophilia
New evidence from real-life clinical practice in the UK, presented today at the World Federation of Haemophilia (WFH) 2018 World Congress in Glasgow, shows that people with haemophilia A treated with an extended half-life (EHL) clotting factor have fewer bleeds than with previously available treatments.